Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the presence of an expanded somatic blood-cell clone in persons without other hematologic abnormalities, is common among older persons and is associated with an increased risk of hematologic cancer. We previously found preliminary evidence for an association between CHIP and atherosclerotic cardiovascular disease, but the nature of this association was unclear. METHODS: We used whole-exome sequencing to detect the presence of CHIP in peripheral-blood cells and associated such presence with coronary heart disease using samples from four case-control studies that together enrolled 4726 participants with coronary heart disease and 3529 controls. To assess causality, we perturbed the function of Tet2, the second most commonly mutated gene linked to clonal hematopoiesis, in the hematopoietic cells of atherosclerosis-prone mice. RESULTS: In nested case-control analyses from two prospective cohorts, carriers of CHIP had a risk of coronary heart disease that was 1.9 times as great as in noncarriers (95% confidence interval [CI], 1.4 to 2.7). In two retrospective case-control cohorts for the evaluation of early-onset myocardial infarction, participants with CHIP had a risk of myocardial infarction that was 4.0 times as great as in noncarriers (95% CI, 2.4 to 6.7). Mutations in DNMT3A, TET2, ASXL1, and JAK2 were each individually associated with coronary heart disease. CHIP carriers with these mutations also had increased coronary-artery calcification, a marker of coronary atherosclerosis burden. Hypercholesterolemia-prone mice that were engrafted with bone marrow obtained from homozygous or heterozygous Tet2 knockout mice had larger atherosclerotic lesions in the aortic root and aorta than did mice that had received control bone marrow. Analyses of macrophages from Tet2 knockout mice showed elevated expression of several chemokine and cytokine genes that contribute to atherosclerosis. CONCLUSIONS: The presence of CHIP in peripheral-blood cells was associated with nearly a doubling in the risk of coronary heart disease in humans and with accelerated atherosclerosis in mice. (Funded by the National Institutes of Health and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“That subjects with clonal hematopoiesis are more susceptible to develop nonhematological, most notably cardiovascular, disease”
From Aging of hematopoietic stem cells (2018) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings are supported by recent findings demonstrating a causal link between mutations in HSPCs in the context of clonal hematopoiesis with indeterminate origin and altered transcriptional output of macrophages, which affect the vascular wall and contributes to atherosclerosis.83,84”
From Inflammatory bone marrow microenvironment (2019) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As CHIP-associated mutations are known to alter the development and function of myeloid cells”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tet2 and Ppm1d mutant murine models have demonstrated an increased inflammatory signature in mutant macrophages, with heightened inflammatory cytokine production upon pro-inflammatory stimulation in vitro [31,32,69,70].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated IL-8 and IL-1β levels have been reported in patients with TET2 CH in the Pakistan Risk of Myocardial Infarction Study (PROMIS) [20,32]”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [32]
Experimental — accuracy not yet measured
38 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Self-citationMacrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Self-citationAge-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339
Cited by
Items 401–500 of 1,015
Chavakis, T., Wielockx, B., & Hajishengallis, G. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-052521-013627 · Cited by 76
Issa, G. C., Kantarjian, H. M., Gonzalez, G. N., Borthakur, G., Tang, G., Wierda, W., Sasaki, K., Short, N. J., Ravandi, F., Kadia, T., et al. (2017) · Blood · doi:10.1182/blood-2017-07-792143 · Cited by 72
Pronk, E., & Raaijmakers, M. H. G. P. (2019) · Blood · doi:10.1182/blood-2018-10-844639 · Cited by 85
Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals
van Zeventer, I. A., de Graaf, A. O., Wouters, H. J., Van der Reijden, B. A., van der Klauw, M., de Witte, T. M., Jonker, M. A., Malcovati, L., Jansen, J. H., & Huls, G. (2020) · Blood · doi:10.1182/blood.2019004362 · Cited by 73
Márquez, E. J., Trowbridge, J. J., Kuchel, G. A., Banchereau, J., & Ucar, D. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00183-z · Cited by 81
“The risk of cardiovascular disease more than doubles in individuals with clonal hematopoiesis [57, 60], which is as great or greater than well-described risk factors such lowdensity lipoprotein (LDL) cholesterol level and blood pressure.”
BackgroundAssessing the Role of Rare Genetic Variation in Patients With Heart Failure
Povysil, G., Chazara, O., Carss, K. J., Deevi, S. V. V., Wang, Q., Armisen, J., Paul, D. S., Granger, C. B., Kjekshus, J., Aggarwal, V., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2020.6500 · Cited by 73
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years
Rossi, M., Meggendorfer, M., Zampini, M., Tettamanti, M., Riva, E., Travaglino, E., Bersanelli, M., Mandelli, S., Antonella Galbussera, A., Mosca, E., et al. (2021) · Blood · doi:10.1182/blood.2021011320 · Cited by 70
Muhandiramge, J., Zalcberg, J. R., Londen, G. J. V., Warner, E. T., Carr, P. R., Haydon, A. M., & Orchard, S. G. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01309-w · Cited by 84
Screening for Coronary Artery Disease in Cancer Survivors
Velusamy, R., Nolan, M. T., Murphy, A. J., Thavendiranathan, P., & Marwick, T. H. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.12.007 · Cited by 90
“9 times increment of incident coronary heart disease when compared with control subjects, and patients <50 years of age with clonal hematopoiesis mutations have a 4-fold increment of premature events.(72) This is supported by a recent study showing that in patients treated with intensive chemotherapy for acute myeloid…”
BackgroundResultYang, K., & Song, M. J. (2023) · Nutrients · doi:10.3390/nu15183970 · Cited by 88
Csiszár, A., Ungvari, A., Patai, R., Gulej, R., Yabluchanskiy, A., Benyó, Z., Kovács, I., Sótonyi, P., Kirkpartrick, A. C., Prodan, C. I., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01139-7 · Cited by 79
“The role of immune cells, particularly Clonal Hematopoiesis of Indeterminate Potential (CHIP), is critical in this context [145, 157–162].”
BackgroundGanuza, M., Hall, T., Finkelstein, D., Wang, Y.-D., Chabot, A., Kang, G., Bi, W., Wu, G., & McKinney-Freeman, S. (2019) · Blood · doi:10.1182/blood-2018-09-873059 · Cited by 73
Cell‐free tumour DNA testing for early detection of cancer – a potential future tool
Barbany, G., Arthur, C., Liedén, A., Nordenskjöld, M., Rosenquist, R., Tesi, B., Wallander, K., & Tham, E. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12897 · Cited by 87
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review
Arguelles, O. C., Jaiswal, S., Shlush, L. I., Moslehi, J. J., Schimmer, A. D., Barac, A., & Thavendiranathan, P. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0302 · Cited by 79
Self-citationTet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis
Pandey, S. P., Bender, M. J., McPherson, A. C., Phelps, C. M., Sanchez, L. M., Rana, M., Hedden, L., Sangani, K. A., Chen, L., Shapira, J. H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.05.006 · Cited by 72
DNA methylation processes in atherosclerotic plaque
Aavik, E., Babu, M., & Ylä‐Herttuala, S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.006 · Cited by 83
Karantanos, T., Chaturvedi, S., Braunstein, E. M., Spivak, J. L., Resar, L. M. S., Karanika, S., Williams, D. M., Rogers, O. C., Gocke, C. D., & Moliterno, A. R. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001407 · Cited by 75
“Importantly, in the population at large, higher clonal hematopoiesis rates not only associate with higher hematologic malignancy rates but also with higher cancer rates overall, whether MPN or non-MPN populations(28,34,35) were ascertained, and higher all-cause mortality.(36) These forces combine in men with MPN to in…”
BackgroundKraler, S., Libby, P., Evans, P. C., Akhmedov, A., Schmiady, M. O., Reinehr, M., Camici, G. G., & Lüscher, T. F. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.121.316256 · Cited by 65
Self-citationA new classification of cardio-oncology syndromes
de Boer, R. A., Aboumsallem, J. P., Bračun, V., Leedy, D. J., Cheng, R. K.-H., Patel, S., Rayan, D., Zaharova, S., Rymer, J. A., Kwan, J. M., et al. (2021) · Cardio-Oncology · doi:10.1186/s40959-021-00110-1 · Cited by 78
Somatic mutations provide important and unique insights into the biology of complex diseases
Ólafsson, S., & Anderson, C. A. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.06.012 · Cited by 76
Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis
Koelwyn, G. J., Aboumsallem, J. P., Moore, K. J., & de Boer, R. A. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.09.008 · Cited by 74
Genetics of smoking and risk of clonal hematopoiesis
Levin, M. G., Nakao, T., Zekavat, S. M., Koyama, S., Bick, A. G., Niroula, A., Ebert, B. L., Damrauer, S. M., & Natarajan, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-09604-z · Cited by 75
“We aimed to (1) confirm observational associations between smoking and common manifestations of somatic mutation (mCA and CHIP), and (2) estimate putative causal associations between smoking and these outcomes within the MR framework.”
BackgroundSelf-citationLongitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
Uddin, M. M., Zhou, Y., Bick, A. G., Burugula, B. B., Jaiswal, S., Desai, P., Honigberg, M. C., Love, S.-A., Barac, A., Hayden, K. M., et al. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00278-9 · Cited by 70
“While CHIP is a risk factor for hematologic malignancy and all-cause mortality [3, 7, 8], a number of analyses have shown an association with atherosclerotic cardiovascular disease [4, 9, 10].”
BackgroundSelf-citationMas‐Peiró, S., Abplanalp, W. T., Rasper, T., Berkowitsch, A., Leistner, D. M., Dimmeler, S., & Zeiher, A. M. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad093 · Cited by 74
Novel Insights into the Molecular Mechanisms of Atherosclerosis
Wojtasińska, A., Frąk, W., Lisińska, W., Sapeda, N., Młynarska, E., Rysz, J., & Franczyk, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713434 · Cited by 76
Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis
Stacey, S. N., Zink, F., Halldorsson, G. H., Stefansdottir, L., Gudjonsson, S. A., Einarsson, G., Hjörleifsson, G., Eiriksdottir, T., Helgadottir, A., Björnsdottir, G., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01555-z · Cited by 69
“Studies that reported an association between CH and CVD received a great deal of attention, having been reviewed extensively 15,21,22 .”
BackgroundMalignant JAK-signaling: at the interface of inflammation and malignant transformation
Perner, F., Pahl, H. L., Zeiser, R., & Heidel, F. H. (2025) · Leukemia · doi:10.1038/s41375-025-02569-8 · Cited by 77
“Seminal studies have demonstrated that individuals with clonal hematopoiesis (CHIP) had an increased risk of coronary heart disease and ischemic stroke [4, 264, 265].”
Hajishengallis, G., Li, X., Divaris, K., & Chavakis, T. (2022) · Periodontology 2000 · doi:10.1111/prd.12421 · Cited by 76
Ultraviolet radiation shapes dendritic cell leukaemia transformation in the skin
Griffin, G. K., Booth, C. A. G., Togami, K., Chung, S. S., Ssozi, D., Verga, J. A., Bouyssou, J., Lee, Y. S., Shanmugam, V., Hornick, J. L., et al. (2023) · Nature · doi:10.1038/s41586-023-06156-8 · Cited by 76
Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs
Hosseini, M., Voisin, V., Chegini, A., Varesi, A., Cathelin, S., Ayyathan, D. M., Liu, A. C. H., Yang, Y., Wang, V. Y., Maher, A., et al. (2025) · Nature · doi:10.1038/s41586-025-08871-w · Cited by 83
NLRP3 and cancer: Pathogenesis and therapeutic opportunities
Tengesdal, I. W., Dinarello, C. A., & Marchetti, C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108545 · Cited by 78
Alterations to DNMT3A in Hematologic Malignancies
Venugopal, K., Feng, Y., Shabashvili, D. E., & Guryanova, O. A. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3033 · Cited by 76
Bick, A. G., Popadin, K., Thorball, C. W., Uddin, M. M., Zanni, M. V., Yu, B., Cavassini, M., Rauch, A., Tarr, P., Schmid, P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04308-2 · Cited by 73
Self-citationClonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML
Valent, P., Kern, W., Hoermann, G., Feenstra, J. D. M., Sotlar, K., Pfeilstöcker, M., Germing, U., Sperr, W. R., Reiter, A., Wolf, D. G. F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030789 · Cited by 74
“In addition, these patients may be at relatively high risk to develop progressive atherosclerosis and related cardiovascular disorders [19,29].”
BackgroundClonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure
Yura, Y., Sano, S., & Walsh, K. X. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.08.006 · Cited by 76
“, in the absence of overt changes in erythrocytes, platelets, or leukocytes) (40,46,56).”
BackgroundResultInfluentialRuscica, M., Penson, P. E., Ferri, N., Sirtori, C. R., Pirro, M., Mancini, G. B. J., Sattar, N. A., Toth, P. P., Sahebkar, A., Lavie, C. J., et al. (2021) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2021.06.010 · Cited by 74
Giant cell arteritis: reviewing the advancing diagnostics and management
Bilton, E. J., & Mollan, S. P. (2023) · Eye · doi:10.1038/s41433-023-02433-y · Cited by 72
“Preliminary works exploring a potential correlation between CHIP and the development of GCA seem to corroborate this association [35].”
InfluentialJak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk
Liu, W., Pircher, J., Schuermans, A., Ain, Q. U., Zhang, Z., Honigberg, M. C., Yalçınkaya, M., Nakao, T., Pournamadri, A., Xiao, T., et al. (2023) · Blood · doi:10.1182/blood.2023022260 · Cited by 73
Self-citationGeroscience and pathology: a new frontier in understanding age-related diseases
Fekete, M., Major, D., Fehér, Á., Fazekas‐Pongor, V., & Lehoczki, A. (2024) · Pathology & Oncology Research · doi:10.3389/pore.2024.1611623 · Cited by 70
Wouters, H. J. C. M., Mulder, R., van Zeventer, I. A., Schuringa, J. J., van der Klauw, M. M., van der Harst, P., Diepstra, A., Mulder, A. B., & Huls, G. A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020003323 · Cited by 74
“5% to 1% annual risk of developing a hematologic malignancy and increases an individual’s risk of experiencing a cardiovascular event.(10,14,20) CHmay also be detected in the presence of 1 or more unexplained cytopenias, a condition referred to as clonal cytopenia of unknown significance.”
BackgroundGenome editing in cardiovascular diseases
(2021) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2021.01.021 · Cited by 65
Clonal hematopoiesis in sickle cell disease
Pincez, T., Lee, S. S. K., Ilboudo, Y., Preuss, M., Pham Hung d’Alexandry d’Orengiani, A.-L., Bartolucci, P., Galactéros, F., Joly, P., Bauer, D. E., Loos, R. J. F., et al. (2021) · Blood · doi:10.1182/blood.2021011121 · Cited by 66
Immune Mechanisms of Plaque Instability
Gerhardt, T., Haghikia, A., Stapmanns, P., & Leistner, D. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.797046 · Cited by 77
“The risk of early-onset MI (<50 years old) quadruples in CHIP carriers as compared to non-carriers (138).”
BackgroundInfluentialWilde, A. A. M., Semsarian, C., Márquez, M. F., Shamloo, A. S., Ackerman, M. J., Ashley, E. A., Sternick, E. B., Barajas-Martínez, H., Behr, E. R., Bezzina, C. R., et al. (2022) · Journal of Arrhythmia · doi:10.1002/joa3.12717 · Cited by 79
Clonal Hematopoiesis and Its Impact on Human Health
Ahmad, H., Jahn, N., & Jaiswal, S. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-112347 · Cited by 66
Self-citationJAK2-mutant clonal hematopoiesis is associated with venous thromboembolism
Zon, R. L., Sekar, A., Clapham, K. R., Oren, O., Niroula, A., Bick, A. G., Gibson, C. J., Griffin, G. K., Uddin, M. M., Neuberg, D. S., et al. (2024) · Blood · doi:10.1182/blood.2024024187 · Cited by 74
Self-citationMast Cells in Cardiovascular Disease: From Bench to Bedside
Hermans, M. A. W., van Lennep, J. E. R., van Daele, P. L. A., & Bot, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143395 · Cited by 66
“Non-mast cell clonal hematopoiesis is also associated with an increased risk of cardiovascular disease: In a large case-control study, the presence of one or more mutations without overt hematological disease leads to a doubled risk of coronary heart disease [59].”
BackgroundInflammation in Coronary Atherosclerosis and Its Therapeutic Implications
Montarello, N. J., Nguyen, M. T., Wong, D. T. L., Nicholls, S. J., & Psaltis, P. J. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07106-6 · Cited by 70
Clonal hematopoiesis as a model for premalignant changes during aging
Steensma, D. P., & Ebert, B. L. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.001 · Cited by 65
“Clinical consequences of CHIP: Other disorders Individuals with CHIP also have an increased risk of a cardiovascular event [57 − 59].”
Self-citationClonal hematopoiesis in cancer
Park, S. J., & Bejar, R. L. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.02.001 · Cited by 74
Midic, D., Rinke, J., Perner, F., Müller, V., Hinze, A., Pester, F., Landschulze, J., Ernst, J., Gruhn, B., Matziolis, G., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0869-y · Cited by 63
Stengel, A., Baer, C. R., Walter, W., Meggendorfer, M., Kern, W., Haferlach, T., & Haferlach, C. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004668 · Cited by 67
“T-cell acute lymphoblastic leukemia T-ALL 101 37 (11-91) 2”
Interleukin-1 (IL-1) and the inflammasome in cancer
Prêtre, V., Papadopoulos, D., Regard, J. B., Pelletier, M. R., & Woo, J. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155850 · Cited by 70
Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock
Scolari, F. L., Abelson, S., Brahmbhatt, D. H., Medeiros, J. J. F., Fan, C. S., Fung, N. L., Mihajlovic, V., Anker, M. S., Otsuki, M., Lawler, P. R., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2588 · Cited by 66
Functional diversity of cardiac macrophages in health and disease
Yang, S. H., Penna, V. R., & Lavine, K. J. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01109-8 · Cited by 73
Hoogeveen, R. M., Nahrendorf, M., Riksen, N. P., Netea, M. G., de Winther, M. P. J., Lutgens, E., Nordestgaard, B. G., Neidhart, M., Stroes, E. S. G., Catapano, A. L., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx581 · Cited by 70
“of monocytes and macrophages and thereby aggravate atherosclerosis as shown in a murine model.(42) In this murine model not only increased atherosclerosis was found in TET2 mutation but”
Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis
Baumer, Y., Ng, Q., Sanda, G. E., Dey, A. K., Teague, H., Sorokin, A. V., Dagur, P. K., Silverman, J. I. M., Harrington, C. L., Rodante, J. A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97179 · Cited by 69
“Human and mouse macrophages and their precursors mouse BM cells and human PBMCs were treated as indicated in Figure 4, A, C, G, and H, and Supplemental Figure 6, A and D. Afterward, cellular mitochondrial ROS were labeled using 2.5 μ M MitoSOX (Thermo Fisher Scientific) for 15 minutes at 37°C 5% CO 2 in HBSS without s…”
BackgroundInfluentialGondek, L. P., & DeZern, A. E. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30211-x · Cited by 63
The Molecular Genetics of Myeloproliferative Neoplasms
Marneth, A. E., & Mullally, A. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034876 · Cited by 69
“…andpromote the transition from JAK2V617F clonal hematopoiesis to MPN. Recent studies indicate that JAK2V617F CHIP is itself a clinically relevant entity, being associated with an increased risk of both atherosclerotic heart disease (Jaiswal et al. 2017) and venous thrombosis (Wolach et al. 2018).”
BackgroundKestenbaum, B. R., Bick, A. G., Vlasschaert, C., Rauh, M. J., Lanktree, M. B., Franceschini, N., Shoemaker, M. B., Harris, R. C., Psaty, B. M., Köttgen, A., et al. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.08.014 · Cited by 66
“36)d No 11,002 3 [3-4] 8 [7-15] 2,041 1.”
BackgroundInfluentialSelf-citationAnemia and Its Connections to Inflammation in Older Adults: A Review
Wacka, E., Nicikowski, J., Jarmużek, P., & Zembroń-Łacny, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072049 · Cited by 84
“Furthermore, studies have also demonstrated correlations with an increase in inflammatory markers such as CRP, IL-1b, and IL-18, but with a decrease in hemoglobin [98,99,101].”
BackgroundASXL1 mutation in clonal hematopoiesis
Fujino, T., & Kitamura, T. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.002 · Cited by 70
Guan, Y., Tiwari, A. D., Phillips, J. G., Hasipek, M., Grabowski, D., Pagliuca, S., Gopal, P., Kerr, C. M., Ademà, V., Radivoyevitch, T., et al. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0173 · Cited by 64
“In the context of CHIP, eliminating and restricting the growth of TET2MT cells by TET inhibition are highly relevant not only to myeloid malignancies and associated disorders but also to the increased risk of cardiovascular disorders (10, 38, 39).”
BackgroundClonal Hematopoiesis and Atherosclerosis
(2017) · New England Journal of Medicine · doi:10.1056/nejmc1710381 · Cited by 62
Self-citationClonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
Natarajan, P., Jaiswal, S., & Kathiresan, S. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001926 · Cited by 63
Self-citationRisk and timing of cardiovascular death among patients with myelodysplastic syndromes
Brunner, A. M., Blonquist, T. M., Hobbs, G. S., Amrein, P. C., Neuberg, D. S., Steensma, D. P., Abel, G. A., & Fathi, A. T. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017010165 · Cited by 63
“Recurrent somatic mutations associated with myeloid malignancies, in particular DNMT3A, TET2, and ASXL1, are associated with an increased rate of incident coronary heart disease and ischemic stroke among patients with CHIP.13,15 This may relate to an interaction between the clonal cells and the endothelium or to a sha…”
BackgroundSelf-citationMasselli, E., Pozzi, G., Gobbi, G., Merighi, S., Gessi, S., Vitale, M., & Carubbi, C. (2020) · Cells · doi:10.3390/cells9092136 · Cited by 69
Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia
Lundgren, S., Keränen, M. A. I., Kankainen, M., Huuhtanen, J., Walldin, G., Kerr, C. M., Clemente, M. J., Ebeling, F. T., Rajala, H. L. M., Brück, O. E., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01231-3 · Cited by 66
Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer
Wang, Y., Wang, Y., Han, X., Sun, J. H., Li, C., Adhikari, B. K., Zhang, J., Miao, X., & Chen, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.727487 · Cited by 71
“Moreover, persistent chronic inflammatory state positively feeds back into somatic mutations leading to increased CHIP-associated mutations, promoting the development and progression of atherosclerosis (25–28).”
BackgroundInfluentialBöhme, M., Desch, S., Rosołowski, M., Scholz, M. R., Krohn, K., Buttner, P. G., Cross, M. A., Kirchberg, J., Rommel, K., Pöss, J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.740 · Cited by 64
Shi, C., Aboumsallem, J. P., Suthahar, N., de Graaf, A. O., Jansen, J. H., van Zeventer, I. A., Bračun, V., de Wit, S., Screever, E. M., van den Berg, P. F., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2715 · Cited by 64
Risk prediction for clonal cytopenia: multicenter real-world evidence
Xie, Z., Komrokji, R. S., Al‐Ali, N., Regelson, A., Geyer, S. M., Patel, A. A., Saygin, C., Zeidan, A. M., Bewersdorf, J. P., Mendez, L., et al. (2024) · Blood · doi:10.1182/blood.2024024756 · Cited by 79
Age-related clonal haemopoiesis is associated with increased epigenetic age
Robertson, N. A., Hillary, R. F., McCartney, D. L., Terradas-Terradas, M., Higham, J., Sproul, D., Deary, I. J., Kirschner, K., Marioni, R. E., & Chandra, T. (2019) · Current Biology · doi:10.1016/j.cub.2019.07.011 · Cited by 56
N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm
Craver, B. M., Ramanathan, G., Hoang, S., Chang, X., Luque, L. F. M., Brooks, S. A., Lai, H. Y., & Fleischman, A. G. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000967 · Cited by 66
Sex-Specific Effects of the Nlrp3 Inflammasome on Atherogenesis in LDL Receptor-Deficient Mice
Chen, S., Markman, J. L., Shimada, K., Crother, T. R., Lane, M. E., Abolhesn, A., Shah, P. K., & Arditi, M. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.03.016 · Cited by 74
“Fuster JJ, MacLauchlan S, Zuriaga MA, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.”
BackgroundInfluentialClonal Hematopoiesis: From Mechanisms to Clinical Intervention
Köhnke, T., & Majeti, R. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0901 · Cited by 66
Nanoimmunotherapy to treat ischaemic heart disease
Duivenvoorden, R., Senders, M. L., van Leent, M. M. T., Pérez‐Medina, C., Nahrendorf, M., Fayad, Z. A., & Mulder, W. J. M. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0073-1 · Cited by 65
Clonal Hematopoiesis Before, During, and After Human Spaceflight
Mencia-Trinchant, N., MacKay, M. J., Chin, C. R., Afshinnekoo, E., Foox, J., Meydan, C., Butler, D., Mozsary, C., Vernice, N. A., Darby, C. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108458 · Cited by 68
“CH can be pro-inflammatory and, through this mechanism, is thought to impact cardiovascular health based on data from model systems and humans (Calvillo-Arg€ uelles et al., 2019; Fuster et al., 2017; Jaiswal et al., 2017; Sano et al., 2018; Wang et al., 2020).”
BackgroundGenetic heterogeneity of cytogenetically normal AML with mutations of CEBPA
Konstandin, N. P., Pastore, F., Herold, T., Dufour, A. M., Rothenberg‐Thurley, M., Hinrichsen, T., Ksienzyk, B., Tschuri, S., Schneider, S., Hoster, E., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018016840 · Cited by 64
“Recent data indicate that healthy individuals with clonal hematopoiesis of indeterminate potential have a higher risk of cardiovascular disease.(34) In a logistic regression model, the CCS score for biCEBPA-mutated patient samples was prognostic for patients in CR.”
BackgroundThe epigenetically-encoded memory of the innate immune system
Sun, S., & Barreiro, L. B. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.02.002 · Cited by 68
“immune cell epigenetics, but come closer to understanding how mutations in epigenetic regulators influence susceptibility to a number of modern-age diseases including cancer [24,25] and atherosclerosis [26,27].”
Ortmann, C. A., Dorsheimer, L., Abou-El-Ardat, K., Hoffrichter, J., Assmus, B., Bonig, H., Scholz, A., Pfeifer, H., Martin, H., Schmid, T., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.064 · Cited by 60
Cremer, S., Kirschbaum, K., Berkowitsch, A., John, D., Kiefer, K. C., Dorsheimer, L., Wagner, J. U. G., Rasper, T., Abou‐El‐Ardat, K., Aßmus, B., et al. (2020) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.003003 · Cited by 65
Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress
Seyfried, A. N., Maloney, J., & MacNamara, K. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01499 · Cited by 68
“Clonal hematopoiesis, while not necessarily sufficient to induce hematologic disease, has been demonstrated to impact mortality associated with cardiovascular disease (190).”
BackgroundTET-Mediated Epigenetic Regulation in Immune Cell Development and Disease
Tsiouplis, N. J., Bailey, D. W., Chiou, L. F., Wissink, F. J., & Tsagaratou, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.623948 · Cited by 68
“Competitive transfer of Tet2-deficient bone marrow cells resulted in enlarged atherosclerotic lesions in irradiated, atherosclerosis-prone mice that are deficient for lowdensity lipoprotein receptor (Ldrl) (Fuster et al., 2017; Jaiswal et al., 2017).”
BackgroundClonal hematopoiesis in sickle cell disease
Liggett, L. A., Cato, L. D., Weinstock, J. S., Zhang, Y., Nouraie, S. M., Gladwin, M. T., Garrett, M. E., Ashley-Koch, A., Telen, M. J., Custer, B., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156060 · Cited by 57
“mutations in the blood were identified by GATK Mutect2 using a ’panel of normals’ to correct for genomic loci that were hotspots for sequencing artifacts, followed by filtering of identified loci to those that are reliably classified as pre-leukemic driver mutations [15].”
Self-citationSymptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines
Kang, Y., Assunção, B. M. B. L., Denduluri, S., McCurdy, S. R., Luger, S. M., Lefebvre, B., Carver, J. R., & Scherrer‐Crosbie, M. (2019) · JACC CardioOncology · doi:10.1016/j.jaccao.2019.10.008 · Cited by 62
“In addition, the presence of several somatic mutations frequently found in myeloid malignancies has been associated with incident coronary heart disease, early-onsetmyocardial infarction, and ischemic stroke (32,33).”
BackgroundThe Clinical Management of Clonal Hematopoiesis
Bolton, K. L., Zehir, A., Ptashkin, R. N., Patel, M. A., Gupta, D., Sidlow, R., Papaemmanuil, E., Berger, M. F., & Levine, R. L. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.11.006 · Cited by 64
Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications
Sterpetti, A. V. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00891-3 · Cited by 65
Aging of human hematopoietic stem cells is linked to changes in Cdc42 activity
Amoah, A., Keller, A., Emini, R., Hoenicka, M., Liebold, A., Vollmer, A., Eiwen, K., Soller, K., Sakk, V., Zheng, Y., et al. (2021) · Haematologica · doi:10.3324/haematol.2020.269670 · Cited by 62
“Another possibility remains that an elevated repopulation potential of aged human HSC could be driven by the presence of individual clones(43) linked to aging-related clonal hematopoiesis reported for a certain percentage of the elderly.(44) Most human studies though demonstrated clonal hematopoiesis only in periphera…”
Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies
Camacho, V., Kuznetsova, V., & Welner, R. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.772408 · Cited by 68
Arends, C. M., Dimitriou, S., Stahler, A., Hablesreiter, R., Strzelecka, P. M., Stein, C. M., Tilgner, M., Saiki, R., Ogawa, S., Bullinger, L., et al. (2021) · Blood · doi:10.1182/blood.2021014108 · Cited by 63
Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations
Arguelles, O. C., Schöffel, A. C., Capo‐Chichi, J., Abdel-Qadir, H. M., Schuh, A. C., Estrada, M. C., Liu, S., Gupta, V. K., Schimmer, A. D., Yee, K. W. L., et al. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.11.008 · Cited by 64
“These associations are supported by robust evidence of causality from animal models and translational experiments.(7,24) Although it is likely that the presence of somatic mutations described in CHIP (ie, CHIPrelated mutations) when also identified in patients with AML may similarly increase the incidence of CVD, this…”
BackgroundSelf-citationMorrison, A. M., Sullivan, A. E., & Aday, A. W. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.04.004 · Cited by 75
Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study
Ahn, H., An, H. Y., Ryu, G., Lim, J., Sun, C.-H., Song, H., Choi, S., Lee, H., Maurer, T. M., Nachun, D. C., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehad869 · Cited by 66
Self-citationSingh, J., Li, N., Ashrafi, E., Thảo, L. T. P., Curtis, D. J., Wood, E. M., & McQuilten, Z. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013228 · Cited by 66
“7,15,25,27,51 As people with CHIP are increasingly being identi fi ed in routine clinical practice, it is important to understand the prognostic implications of CHIP to guide the appropriate monitoring or surveillance of individuals.”
BackgroundInflammageing, a targetable pathway for preventing cardiovascular diseases
Aranda, J. F., Ramírez, C. M., & Mittelbrunn, M. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae240 · Cited by 73
“15,16 (2) Thymus involution .”
Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis
Martin, K. A. (2017) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-017-0400-3 · Cited by 62
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis
Guglielmelli, P., Carobbio, A., Rumi, E., Stefano, V. D., Mannelli, L., Mannelli, F., Rotunno, G., Coltro, G., Betti, S., Cavalloni, C., et al. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-0289-2 · Cited by 60
Roadmap for alleviating the manifestations of ageing in the cardiovascular system
Liberale, L., Tual-Chalot, S., Sedej, S., Ministrini, S., Georgiopoulos, G., Grunewald, M., Bäck, M., Bochaton-Piallat, M.-L., Boon, R. A., Ramos, G. C., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01130-5 · Cited by 59
“Although experimental studies have revealed a causal effect of CHIP on atherogenesis 193,198 , there is also evidence to suggest that atherosclerosis-associated inflammation accelerates CHIP 199,200 .”
InfluentialSkuratovskaia, D., Vulf, M. A., Komar, A., Кириенкова, Е. В., & Litvinova, L. S. (2019) · Biomolecules · doi:10.3390/biom9060226 · Cited by 60
“In addition, RG108 showed an inhibitory effect on another DNA methyltransferase 3a (DNMT3A), which is associated with coronary heart disease [71].”
Background
Metadata
- Authors
- Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., Baber, U., Mehran, R., Fuster, V., Danesh, J., Frossard, P., Saleheen, D., Melander, O., Sukhova, G. K., Neuberg, D., Libby, P., Kathiresan, S., & Ebert, B. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- ORCID
- Jaiswal, Siddhartha
- Natarajan, Pradeep
- Silver, Alexander J.
- Gibson, Christopher J.
- Bick, Alexander G.
- McConkey, Marie
- Gupta, Namrata
- Gabriel, Stacey
- Ardissino, Diego
- Baber, Usman
- Mehran, Roxana
- Danesh, John
- Saleheen, Danish
- Melander, Olle
- Sukhova, Galina K.
- Neuberg, Donna
- Libby, Peter
- Kathiresan, Sekar
- Ebert, Benjamin L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-07-13
- Volume
- 377
- Issue
- 2
- Pages
- 111-121
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6717509
- OpenAlex
- W2628145035
- Cited by
- 2,683
- References
- 37
- Citations by year
- 2026: 303 · 2025: 322 · 2024: 347 · 2023: 338 · 2022: 371 · 2021: 303 · 2020: 263 · 2019: 215 · 2018: 169 · 2017: 44
- FWCI
- 143.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/014/24067)
- Novo Nordisk Fonden (NNF14OC0009819, NNF13OC0005339)
- Medical Research Council (MR/L003120/1)
- National Heart, Lung, and Blood Institute (R01HL082945, R01HL080472, RC2HL101834, T32HL116324)
- National Human Genome Research Institute (U54HG003067)
- Fogarty International Center (RC1TW008485)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- clonal hematopoiesis of indeterminate potential, atherosclerotic cardiovascular disease, coronary artery disease, myocardial infarction, coronary artery calcification, TET2 mutation, DNMT3A, ASXL1, JAK2, somatic mutations, atherosclerosis, cytokines and chemokines, macrophages, bone marrow transplantation
- MeSH terms
- Animals, Coronary Disease, Hematopoiesis, Hematopoietic Stem Cells, Humans, Mutation, Risk, Case-Control Studies, Sequence Analysis, DNA, Mice, Knockout, Genetic Predisposition to Disease, Atherosclerosis, Mice, Exome, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.